SOD1 and amyotrophic lateral sclerosis: We aim to determine the number of people with pathogenic SOD1 variants in the UK Biobank (UKB), to address a critical gap between clinical and genetic prevalence of SOD1-ALS.<h4>Methods</h4>We analyzed SOD1 variants within exome sequencing data from 470,000 individuals aged over 40 years.